OmniaLuo (OTCBB: OLOU) Closed at $1.35. Today announced that it achieved overwhelming success with the exhibition of its 2008 Summer Line at the 16th annual China International Clothing and Accessories Fair (“CHIC 2008”) in Beijing from March 28-31, 2008. Over the four-day show, OmniaLuo received international exposure to the more than 120,000 attendees and enlisted 15 independent distributors (similar to franchisees) for stores to be opened in 2008.
“To put our success at CHIC 2008 in perspective, in over a year of operations we have opened 135 high-margin independent distributor stores. We just potentially grew this total by over 10% - in only 4 days,” stated Ms. Cindy Luo, Chairwoman and CEO. “As these 15 new stores open as anticipated, our total store count will grow to 211 – already 84% of the way to our 2008 goal of at least 250 stores. Moreover, the outstanding response our Summer Line 2008 received further strengthened the OMNIALOU brand and paves the way for our ultimate international expansion.”
What They Do: OmniaLuo, based in China’s fashion capital of Shenzhen, is in the business of designing, developing, marketing and distributing fine women’s apparel under the brand name OmniaLuo. OmniaLuo's apparel embodies elegance, femininity and sophistication for China’s rapidly growing class of urban and affluent female professionals. With its rapid and strategic expansion plan, OmniaLuo plans to increase its retail presence throughout China from its current 211 stores to more than 250 stores by year end 2008. Under the leadership of Cindy Luo, the Company’s founder and award winning chief designer, OminaLuo is positioned to become the Chinese brand equivalent of Donna Karan or Liz Claiborne.
How They Trade: OLOU has a 52 week high of $2.15 and a 52 week low of $1.10. Volume averages approximately 4K shares a day.
Altera Corporation (Nasdaq: ALTR) Closed at $19.20. Today announced first quarter sales of $336.1 million, up 4 percent from the fourth quarter of 2007 and up 10 percent from the first quarter of 2007. First quarter net income was $83.9 million, $0.27 per diluted share, up from net income of $65.5 million, $0.20 per diluted share, in the fourth quarter of 2007.
With the repurchase of 15.5 million shares in the first quarter of 2008, at a cost of $275 million, Altera has completed its previously announced $1.5 billion share repurchase plan. Altera ended the quarter with $995 million in cash and short-term investments.Altera’s board of directors has increased the company’s quarterly cash dividend to $0.05 per share, up from the previous dividend of $0.04 per share. The board of directors has declared that the next quarterly dividend will be paid on June 2, 2008 to shareholders of record on May 12, 2008.
What They Do: Altera’s programmable solutions enable system and semiconductor companies to rapidly and cost-effectively innovate, differentiate and win in their markets.
How They Trade: ALTR has a 52 week high of $26.24 and a 52 week low of $16.21. Volume averages approximately 7.6M shares a day.
IBM (NYSE: IBM) Closed at $120.47. Today announced first- quarter 2008 diluted earnings of $1.65 per share from continuing operations compared with diluted earnings of $1.21 per share in the first quarter of 2007, an increase of 36 percent as reported. First- quarter income from continuing operations was $2.3 billion compared with $1.8 billion in the first quarter of 2007, an increase of 26 percent. Total revenues for the first quarter of 2008 of $24.5 billion increased 11 percent (4 percent, adjusting for currency) from the first quarter of 2007.
What They Do: International Business Machines Corporation (IBM) develops and manufactures information technologies, including computer systems, software, networking systems, storage devices, and microelectronics worldwide. Its Global Technology Services segment offers IT infrastructure and business process services, such as strategic outsourcing, business transformation outsourcing, integrated technology, and maintenance.
How They Trade: IBM has a 52 week high of $121.46 and a 52 week low of $93.91. Volume averages approximately 9.2M shares a day.
Gilead Sciences (Nasdaq: GILD) Closed at $51.80. Today announced its results of operations for the quarter ended March 31, 2008. Total revenues for the first quarter of 2008 were $1.26 billion, up 22 percent compared to total revenues of $1.03 billion for the first quarter of 2007. Net income for the first quarter of 2008 was $496.1 million, or $0.51 per diluted share, including after-tax stock-based compensation expense of $26.0 million. Excluding after-tax stock-based compensation expense, non-GAAP net income for the first quarter of 2008 was $522.1 million, or $0.54 per diluted share, compared to non-GAAP net income of $447.6 million, or $0.46 per diluted share, for the first quarter of 2007, which excluded after-tax stock-based compensation expense of $40.2 million.
What They Do: Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. Gilead’s mission is to advance the care of patients suffering from life-threatening diseases worldwide.
How They Trade: GILD has a 52 week high of $53.20 and a 52 week low of $35.22. Volume averages approximately 9.8M shares a day.
Features available at SmallCapReview.com include in-depth profiles of select Small-Cap/Penny Stocks as well as the most comprehensive and up to date news available on the small-cap market.
SmallCapReview.com is not a registered investment advisor or broker/dealer. No investor should assume that reliance on the views, opinions or recommendations contained herein will produce profitable results. Nothing within our site should be construed as an offer or solicitation to buy or sell products or securities. The companies we profile may lack an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk. SmallCapReview.com may hold positions in securities mentioned herein, and may make purchases or sales in such securities featured on our website or within our reports. In order to be in full compliance with the Securities Act of 1933, Section 17(b), SmallCapReview.com will disclose, what, if any compensation was received for our efforts in researching, presenting and disseminating this information to our subscriber database and featuring the report on our website. SmallCapReview has been compensated two thousand five hundred dollars by a third party APS for its efforts in presenting the OmniaLuo profile on its website and distributing it to its database of subscribers.